Oxycodone Completed Phase 3 Trials for Parkinson's Disease With Severe Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01439100A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain